Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-01-31
1993-04-13
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, 514212, 514218, 5142222, 5142268, 5142285, 5142288, 5142322, 514254, 540545, 540546, 540553, 540575, 540599, 544 61, 544117, 544236, A61K 3150, A61K 31535, A61K 3155, C07D48704
Patent
active
052023249
ABSTRACT:
The imidazo[1,2-b]pyridazine compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or halogen atom, or a lower alkyl group optionally having substituent(s), R.sub.2 and R.sub.3 are, independently, a hydrogen atom, a lower alkyl group optionally having substituent(s), a cycloalkyl group or a phenyl group optionally having substituent(s) or R.sub.2 and R.sub.3 together with the adjacent nitrogen atom to which they bond may form a heterocyclic ring optionally having substituent(s), X is an oxygen atom or S(O).sub.n (n=0 to 2), Alk is a straight or branched chain alkylene group containing 1-10 carbon atoms and optionally having substituent(s), or their pharmaceutically acceptable salts which possess antiallergic, anti-inflammatory and anti-PAF activities, and their production and use.
REFERENCES:
patent: 4330543 (1982-05-01), Baldwin et al.
patent: 4353903 (1982-10-01), Fabiane et al.
patent: 4464372 (1984-08-01), Baldwin et al.
patent: 5145850 (1992-09-01), Miyake et al.
Morrison & Boyd, Organic Chemistry, 5th Ed., Allyn and Bacon, Inc., Boston, (1987) (1959), pp. 702, 703, 953.
Kuriki Hisashi
Kuwahara Masaaki
Miyake Akio
Higel Floyd D.
Takeda Chemical Industries Ltd.
LandOfFree
Imidazopyridazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155543